Results 301 to 310 of about 1,213,487 (359)

Association of integrated biomarkers and progression-free survival prediction in patients with gastroenteropancreatic neuroendocrine tumors undergoing [177Lu]Lu-DOTA-TATE therapy. [PDF]

Theranostics
Herr FL, Dascalescu C, Ebner R, Schnitzer ML, Fabritius MP, Schmid-Tannwald C, Zacherl MJ, Wenter V, Unterrainer LM, Brendel M, Holzgreve A, Werner RA, Auernhammer CJ, Spitzweg C, Knösel T, Burkard T, Ricke J, Heimer MM, Sheikh GT, Cyran CC.   +19 more
europepmc   +1 more source

Heterogeneity of Rheumatoid Arthritis‐Associated Interstitial Lung Disease by Longitudinal Forced Vital Capacity Trajectory and Associations with Disease Outcomes

Arthritis Care &Research, Accepted Article.
Objective We aimed to identify unique disease trajectories within rheumatoid arthritis‐associated interstitial lung disease (RA‐ILD) based on longitudinal forced vital capacity (FVC) values and their associated clinical outcomes. Methods We performed a cohort study of RA‐ILD within the Veterans Health Administration from 1999‐2021. RA‐ILD patients were
Bryant R. England, Yangyuna Yang, Punyasha Roul, Tate M. Johnson, Scott M. Matson, Grant W. Cannon, Brian C. Sauer, Jeffrey R. Curtis, Joshua F. Baker, Ted R. Mikuls   +9 more
wiley   +1 more source

Impact of re-operation on progression-free survival in patients with recurrent GBM: Experience in a tertiary referral center. [PDF]

PLoS One
Darwish H, Diab T, Kawtharani S, Barake M, Ali B, Ramadan N, Fadlallah H, Kekedjian J, Najjar M, Assi HI.   +9 more
europepmc   +1 more source

Serum uric acid levels in older adults: Associations with clinical outcomes and implications for reference intervals in those aged 70 years and over

Arthritis Care &Research, Accepted Article.
Objectives Reports have linked both high and low serum uric acid (SUA) levels to adverse health outcomes. This study aimed to establish a reference interval for SUA in older adults and assessed its association with clinically relevant outcomes in relatively healthy, community‐dwelling individuals aged 70 and older.
Amanda J Rickard, Cammie Tran, Hans G Schneider, Flavia M Cicuttini, Anita E Wluka, Ego Seeman, Johannes T Neumann, Md Nazmul Karim, Zhen Zhou, Sultana Monira Hussain, David P Q Clark, Daniel Clayton‐Chubb, Andrew M Tonkin, Lawrence J Beilin, Robyn L Woods, John J McNeil   +15 more
wiley   +1 more source

Development and validation of an MRI radiomics-based interpretable machine learning model for predicting the progression-free survival in locally advanced nasopharyngeal carcinoma. [PDF]

Quant Imaging Med Surg
Lai P, Chen X, Pei W, Huang X, Fang Z, Yang F, Ying Y, Song Y, Jin W, Lu S, Lu B, Liao H.   +11 more
europepmc   +1 more source

Real-world progression-free survival of CDK4/6 inhibitors plus an aromatase inhibitor in HR-positive/HER2-negative metastatic breast cancer in United States routine clinical practice. [PDF]

ESMO Open
Rugo HS, Layman RM, Lynce F, Liu X, Li B, McRoy L, Cohen AB, Estevez M, Curigliano G, Brufsky A.   +9 more
europepmc   +1 more source

RBIS as a prognostic biomarker for progression-free survival in prostate cancer: insights from bioinformatics and immune infiltration analysis. [PDF]

Discov Oncol
Chen Z, Fang Y, Zhang J.
europepmc   +1 more source

Association between cytokines and progression-free survival in ovarian cancer following CRS/HIPEC treatment. [PDF]

J Ovarian Res
Chen CY, Wang TY, Liu JL, Ou YC, Lee LW, Hung CH, Lee CP, Lung J.   +7 more
europepmc   +1 more source

The Progression-Free-Survival Ratio in Molecularly Aided Tumor Trials: A Critical Examination of Current Practice and Suggestions for Alternative Methods. [PDF]

Biom J
Edelmann D, Terzer T, Horak P, Schlenk R, Benner A.   +4 more
europepmc   +1 more source